全文获取类型
收费全文 | 55325篇 |
免费 | 3501篇 |
国内免费 | 186篇 |
专业分类
耳鼻咽喉 | 490篇 |
儿科学 | 1579篇 |
妇产科学 | 1316篇 |
基础医学 | 7466篇 |
口腔科学 | 958篇 |
临床医学 | 7820篇 |
内科学 | 10586篇 |
皮肤病学 | 792篇 |
神经病学 | 5469篇 |
特种医学 | 1280篇 |
外科学 | 5874篇 |
综合类 | 725篇 |
一般理论 | 75篇 |
预防医学 | 6279篇 |
眼科学 | 891篇 |
药学 | 3475篇 |
1篇 | |
中国医学 | 112篇 |
肿瘤学 | 3824篇 |
出版年
2023年 | 266篇 |
2022年 | 516篇 |
2021年 | 1086篇 |
2020年 | 633篇 |
2019年 | 1105篇 |
2018年 | 1237篇 |
2017年 | 881篇 |
2016年 | 932篇 |
2015年 | 1227篇 |
2014年 | 1664篇 |
2013年 | 2591篇 |
2012年 | 3804篇 |
2011年 | 3990篇 |
2010年 | 2197篇 |
2009年 | 1923篇 |
2008年 | 3610篇 |
2007年 | 3805篇 |
2006年 | 3844篇 |
2005年 | 3697篇 |
2004年 | 3493篇 |
2003年 | 3337篇 |
2002年 | 3177篇 |
2001年 | 439篇 |
2000年 | 355篇 |
1999年 | 548篇 |
1998年 | 645篇 |
1997年 | 612篇 |
1996年 | 499篇 |
1995年 | 449篇 |
1994年 | 439篇 |
1993年 | 421篇 |
1992年 | 310篇 |
1991年 | 262篇 |
1990年 | 262篇 |
1989年 | 267篇 |
1988年 | 270篇 |
1987年 | 228篇 |
1986年 | 229篇 |
1985年 | 231篇 |
1984年 | 302篇 |
1983年 | 319篇 |
1982年 | 339篇 |
1981年 | 313篇 |
1980年 | 305篇 |
1979年 | 173篇 |
1978年 | 157篇 |
1977年 | 169篇 |
1976年 | 123篇 |
1975年 | 108篇 |
1974年 | 138篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
Castano-Jaramillo Lina M. Yamazaki-Nakashimada Marco Antonio O’Farrill-Romanillos Patricia M. Muzquiz Zermeño David Scheffler Mendoza Selma C. Venegas Montoya Edna García Campos Jorge Alberto Sánchez-Sánchez Luz María Gámez González Luisa B. Ramírez López Jesús Moisés Bustamante Ogando Juan Carlos Vásquez-Echeverri Estefanía Medina Torres Edgar Alejandro Lopez-Herrera Gabriela Blancas Galicia Lizbeth Berrón Ruiz Laura Staines-Boone Aidé Tamara Espinosa-Padilla Sara Elva Segura Mendez Nora Hilda Lugo Reyes Saul O. 《Journal of clinical immunology》2021,41(7):1463-1478
Journal of Clinical Immunology - Patients with inborn errors of immunity (IEI) have a compromised or inappropriate immune response. Although they might be considered a high-risk group for severe... 相似文献
995.
996.
Aina Mesquida Teresa Vicente Elena Reigadas María Palomo Carlos Sánchez-Carrillo Patricia Muñoz Jesús Guinea Pilar Escribano 《Clinical microbiology and infection》2021,27(6):915.e5-915.e8
ObjectivesEmergence of azole resistance may contribute to recurrences of vulvovaginal candidiasis. Thus, new drugs are needed to improve the therapeutic options. We studied the in vitro activity of ibrexafungerp and comparators against Candida albicans isolates from vaginal samples and blood cultures. Furthermore, isolates were genotyped to study compartmentalization of genotypes and the relationship between genotype and antifungal susceptibility.MethodsCandida albicans unique patient isolates (n = 144) from patients with clinical suspicion of vulvovaginal candidiasis (n = 72 isolates) and from patients with candidaemia (n = 72) were studied. Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, posaconazole, isavuconazole, clotrimazole, miconazole, micafungin, anidulafungin and ibrexafungerp was tested (EUCAST 7.3.2). Mutations in the erg11 gene were analysed and isolates genotyped.ResultsIbrexafungerp showed high activity (MICs from 0.03 mg/L to 0.25 mg/L) against the isolates, including those with reduced azole susceptibility, and regardless of their clinical source. Fluconazole resistance rate was 7% (n = 5/72) and 1.4% (n = 1/72) in vaginal and blood isolates, respectively. Some amino acid substitutions in the Erg11 protein were observed exclusively in phenotypically fluconazole non-wild type. Population structure analysis suggested two genotype populations, one mostly involving isolates from blood samples (66.3%) and the mostly from vaginal samples (69.8%). The latter group hosted all fluconazole non-wild-type isolates.DiscussionIbrexafungerp shows good in vitro activity against Candida albicans from vaginal samples including phenotypically fluconazole non-wild-type isolates. Furthermore, we found a certain population structure where some genotypes show reduced susceptibility to fluconazole. 相似文献
997.
998.
Dawn Peck Amy White Gisele Pino April Studinski Meghan Strenk Randi Gadea Jennifer Gannon Bryce Heese Esperanza Font-Montgomery Tracy Klug Jennifer Burton George Hoganson Devin Oglesbee Dimitar Gavrilov Dietrich Matern Kimiyo Raymond Piero Rinaldo Silvia Tortorelli 《Molecular genetics and metabolism》2021
999.
1000.
Recent advances in knowledge of the properties of antimicrobial peptides (AMPs) are reviewed. AMPs are typically small, positively charged, amphipathic peptides that interact electrostatically and non-stereospecifically with the bacterial cell membrane, resulting in its permeabilization and cell death. Classes of AMPs, their mechanisms of action, hemolytic activity, and cytotoxicity towards host cells are discussed. A particular focus is AMPs with potential for use in defense against biological warfare agents. Some AMPs cytotoxic to Bacillus anthracis have been described. Synthesis of these peptides in multivalent form leads to a synergistic increase in antibacterial activity. Strategies to enhance the potency, stability, and selectivity of AMPs are discussed. 相似文献